Mark Plavsic, Ph.D.
Mark Plavsic is a member of the Board of Directors of TeraPore. He currently is Chief Technical Officer at Lysogene, a gene therapy company focused on the treatment of orphan diseases of the central nervous system (CNS). Prior to joining Lysogene, Dr. Plavsic was the Head of Process Development and Manufacturing at Torque Therapeutics, where he led multiple functions including process and analytics development, and spearheaded quality control and design across the company’s manufacturing operations. Earlier in his career he held multiple positions with Sanofi Genzyme, AstraZeneca and Invitrogen Corporation.
Dr. Plavsic received his Ph.D. in Virology and Molecular Cell Biology, M.S. in Virology and Immunology, and Doctor of Veterinary Medicine degrees from the University of Belgrade in Yugoslavia. He has a Board certification in Microbiology, subspecialty Virology from the American College of Veterinary Microbiologists.